What’s Causing My Prominent Under-Eye Bags and Dark Circles?

Under-eye bags and dark circles are among the most common cosmetic concerns patients bring to dermatologists and oculoplastic surgeons. While often perceived as purely aesthetic issues, they can reflect a range of underlying anatomical, physiological, and lifestyle-related factors.

Anatomically, prominent under-eye bags typically result from herniation of orbital fat pads—particularly the medial and central fat compartments—that become more visible as the orbital septum weakens with age. This process is accelerated by genetic predisposition, chronic eye rubbing, or conditions like atopy that increase tissue inflammation and laxity.

Dark circles, in contrast, have multiple etiologies. Pigmentary causes include post-inflammatory hyperpigmentation (often linked to chronic allergies or eczema), increased melanin deposition due to sun exposure, or inherent racial melanin variation. Vascular causes involve thinning of the lower eyelid skin—normally only 0.5 mm thick—which allows underlying orbicularis oculi muscle and vasculature to show through as a bluish or grayish hue. Structural shadowing may also contribute, especially when tear trough hollowing creates a contour depression that casts a shadow under ambient light.

Contributing systemic and behavioral factors include sleep deprivation, dehydration, high-salt diets (which promote fluid retention), uncontrolled allergic rhinitis, thyroid dysfunction, and iron deficiency anemia. Certain medications—such as topical prostaglandin analogs used for glaucoma—can also induce periorbital pigmentation or fat redistribution.

A thorough clinical evaluation is essential before treatment planning. This includes assessing skin thickness, fat compartment volume and position, presence of volume loss in adjacent areas (e.g., malar or lateral orbital rim), and ruling out underlying medical conditions. Management strategies vary accordingly: conservative measures (e.g., allergen avoidance, topical retinoids, sunscreen), minimally invasive interventions (e.g., hyaluronic acid fillers for tear trough correction), or surgical options (e.g., transconjunctival blepharoplasty with fat repositioning) may be indicated depending on the dominant pathophysiology.